ARPO - Aerpio Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 529.01M
Enterprise Value 3-21.7M
Trailing P/E N/A
Forward P/E 1-1.33
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.54
Price/Book (mrq)0.62
Enterprise Value/Revenue 3-1.15
Enterprise Value/EBITDA 61.88

Trading Information

Stock Price History

Beta (3Y Monthly) 2.56
52-Week Change 3-82.67%
S&P500 52-Week Change 31.31%
52 Week High 34.2500
52 Week Low 30.6100
50-Day Moving Average 30.7694
200-Day Moving Average 31.4481

Share Statistics

Avg Vol (3 month) 3113.77k
Avg Vol (10 day) 393.23k
Shares Outstanding 527.14M
Float 24.85M
% Held by Insiders 133.64%
% Held by Institutions 126.81%
Shares Short (Jul 31, 2019) 481.94k
Short Ratio (Jul 31, 2019) 41.07
Short % of Float (Jul 31, 2019) 40.35%
Short % of Shares Outstanding (Jul 31, 2019) 40.20%
Shares Short (prior month Jun 28, 2019) 4140.05k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -59.27%
Operating Margin (ttm)-61.48%

Management Effectiveness

Return on Assets (ttm)-12.14%
Return on Equity (ttm)-23.83%

Income Statement

Revenue (ttm)18.82M
Revenue Per Share (ttm)0.46
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)20.16M
EBITDA -11.52M
Net Income Avi to Common (ttm)-11.16M
Diluted EPS (ttm)-0.2750
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)48.16M
Total Cash Per Share (mrq)1.19
Total Debt (mrq)481.34k
Total Debt/Equity (mrq)1.05
Current Ratio (mrq)13.57
Book Value Per Share (mrq)1.13

Cash Flow Statement

Operating Cash Flow (ttm)-26.63M
Levered Free Cash Flow (ttm)-22.96M